Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T20:51:51.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page history shows a new site revision label v3.7.0, replacing the previous v3.6.6. This indicates a system update to the page rendering and history tracking, not a change to study data or content.
    Difference
    0.1%
    Check dated 2026-09-19T22:09:21.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's history rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T18:53:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    No additions or deletions are listed for this study history. As a result, there are no textual changes to interpret.
    Difference
    0.1%
    Check dated 2026-08-15T23:12:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added on 2026-08-06 with a 'Study Status' note, while the prior revision (v3.6.4) was removed on 2026-05-12.
    Difference
    0.3%
    Check dated 2026-08-08T18:02:15.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added to the history, replacing the previous v3.6.3. This reflects a platform/UI update to the record history page rather than any substantive change to the trial data.
    Difference
    0.1%
    Check dated 2026-07-25T08:24:45.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.